Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Zeinab Abdel-All"'
Autor:
Elizabeta B. Mukaetova-Ladinska, Charlotte Graham, Estibaliz Santiago-Mugica, Rajesh N. Kalaria, Mosi Li, Richard J. Q. McNally, Zeinab Abdel-All
Publikováno v:
Journal of Alzheimer's Disease. 71:569-580
Background Discovering biomarkers for dementia is a pivotal step toward successful early diagnosis and treatment. Although plasma biomarkers have been explored, no consensus has been reached. Alpha-synuclein (AS), a 14 kDa synaptic protein associated
Autor:
John T. O'Brien, Joana Andrade, Elizabeta B. Mukaetova-Ladinska, Raj N. Kalaria, Zeinab Abdel-All, Joaquim Alves da Silva
Publikováno v:
International Journal of Geriatric Psychiatry. 30:368-375
Background Clusterin protein in plasma has been found to differentiate between people with and without cognitive changes. However, these findings are not conclusive, despite the clusterin gene variations repeatedly being linked to increased risk for
Autor:
Joana Andrade, Joaquim Alves da Silva, Zeinab Abdel-All, Steven Dodds, John T. O'Brien, Elizabeta B. Mukaetova-Ladinska, Raj N. Kalaria
Publikováno v:
Age and Ageing. 41:408-412
Background: the diagnosis of dementia, in particular Alzheimer’s disease (AD), is enhanced with the use of molecular biomarkers. Since cerebrospinal fluid analysis and molecular neuroimaging are not routinely used in many countries, blood biomarker
Autor:
Jeanette Doherty, G McIntosh, I Milton, Alina Andras, Elizabeta B. Mukaetova-Ladinska, J. Robson, Ian G. McKeith, Evelyn Jaros, E Greally, J Milne, John H. Xuereb, Robert H. Perry, Zeinab Abdel-All, Carol Brayne, Andrea Cleghorn, Joaquim Cerejeira
Publikováno v:
Dementia and Geriatric Cognitive Disorders. 26:32-42
Background: Disease-specific biomarkers should reflect a fundamental feature of neuropathology and be validated in neuropathologically confirmed cases. Several synaptic proteins have been described in cerebrospinal fluid (CSF) of patients with dement
Autor:
Arthur E. Oakley, Mosi Li, Lucy J. L. Craggs, Raj N. Kalaria, Zeinab Abdel-All, William G. Honer, Elizabeta B. Mukaetova-Ladinska, Estibaliz Santiago Mugica
Publikováno v:
Journal of neuropathology and experimental neurology. 74(2)
We previously reported that, in the brains of older patients with vascular dementia (VaD), there is a distinctive accumulation of detergent-extractable soluble amyloid-β, with a predominance of Aβ42 species. It is unclear, however, if tau proteins
Autor:
Joan Milne, William G. Honer, Andrea Cleghorn, Elaine K. Perry, Raj N. Kalaria, Evelyn Jaros, Alina Andras, Robert H. Perry, Zeinab Abdel-All, Elizabeta B. Mukaetova-Ladinska, Gary McIntosh, Ian G. McKeith, Iwo Borr, Jeanette Doherty
Publikováno v:
Journal of neuropathology and experimental neurology. 72(1)
Functional neuroimaging studies have consistently reported abnormalities in the visual cortex in patients with dementia with Lewy bodies (DLB), but their neuropathologic substrates are poorly understood. We analyzed synaptic proteins and choline acet
Autor:
John T. O'Brien, Peter W. James, Elizabeta B. Mukaetova-Ladinska, Richard J. Q. McNally, Zeinab Abdel-All, Raj N. Kalaria, Joana Andrade
Publikováno v:
Journal of Alzheimer's disease : JAD. 32(2)
We report a 16.5% increase in platelet immunoglobulin (Ig) content in subjects with Alzheimer's disease (AD) in relation to cognitively intact individuals (p = 0.021), whereas the plasma Ig levels were unaltered (p = 0.428). The upregulation of plate
Autor:
E. C. Downes, Zeinab Abdel-All, John H. Xuereb, Carol Brayne, Elizabeta B. Mukaetova-Ladinska, E. Grailly, Anthony J. Holland, J. Robson, William G. Honer
Publikováno v:
Neuropathology and applied neurobiology. 34(1)
AIMS This study quantified the density of the synaptic proteins synaptophysin and synaptosomal-associated protein 25-kDa (SNAP-25) in brains from elderly Down's syndrome individuals. METHODS Six areas (frontal, occipital, parietal and temporal lobes,
Autor:
Andrew M. Schaefer, D.M. Turnbull, Joanne Betts, Evelyn Jaros, Robert H. Perry, Zeinab Abdel-All, Robert N. Lightowlers, Robert W. Taylor
Publikováno v:
Neuropathology and applied neurobiology. 32(4)
Mitochondrial DNA (mtDNA) disease is an important genetic cause of neurological disability. A variety of different clinical features are observed and one of the most common phenotypes is MELAS (Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis